Vaxcyte EVP, Chief Scientific Officer and COO Jim Wassil Reports Sale of Common Shares Worth $137,024.083

• Vaxcyte EVP, Chief Scientific Officer and COO Jim Wassil sold 2,250 common shares on Nov. 2, 2026.
• The sales comprised 1,907 shares at $60.779 each and 343 shares at $61.57 each.
• Wassil also exercised stock options for 2,250 common shares at $5.35 each that day.
• His direct holdings totaled 145,435 common shares following the transactions, according to the Form 4 dated Nov. 4, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001813798-26-000025), on November 04, 2026, and is solely responsible for the information contained therein.